1
|
Yu X and Li Z: MicroRNAs regulate vascular
smooth muscle cell functions in atherosclerosis (Review). Int J Mol
Med. 34:923–933. 2014.PubMed/NCBI
|
2
|
Bornfeldt KE and Krebs EG: Crosstalk
between protein kinase A and growth factor receptor signaling
pathways in arterial smooth muscle. Cell Signal. 11:465–477. 1999.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Somjen D, Knoll E, Sharon O, Many A and
Stern N: Calciotrophic hormones and hyperglycemia modulate vitamin
D receptor and 25 hydroxyy vitamin D 1-α hydroxylase mRNA
expression in human vascular smooth muscle cells. J Steroid Biochem
Mol Biol. 148:210–213. 2015. View Article : Google Scholar
|
4
|
Liu N, Bezprozvannaya S, Williams AH, Qi
X, Richardson JA, Bassel-Duby R and Olson EN: microRNA-133a
regulates cardiomyocyte proliferation and suppresses smooth muscle
gene expression in the heart. Genes Dev. 22:3242–3254. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Doe Z, Fukumoto Y, Takaki A, et al:
Evidence for Rho-kinase activation in patients with pulmonary
arterial hypertension. Circ J. 73:1731–1739. 2009. View Article : Google Scholar
|
6
|
Delafontaine P, Song YH and Li Y:
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1
binding proteins in blood vessels. Arterioscler Thromb Vasc Biol.
24:435–444. 2004. View Article : Google Scholar
|
7
|
Fath KA, Alexander RW and Delafontaine P:
Abdominal coarctation increases insulin-like growth factor I mRNA
levels in rat aorta. Circ Res. 72:271–277. 1993. View Article : Google Scholar : PubMed/NCBI
|
8
|
Maile LA, Busby WH, Sitko K, et al:
Insulin-like growth factor-I signaling in smooth muscle cells is
regulated by ligand binding to the 177CYDMKTTC184 sequence of the
beta3-subunit of alphaVbeta3. Mol Endocrinol. 20:405–413. 2006.
View Article : Google Scholar
|
9
|
Valinezhad Orang A, Safaralizadeh R1 and
Kazemzadeh-Bavili M: Mechanisms of miRNA-mediated gene regulation
from common downregulation to mRNA-specific upregulation. Int J
Genomics. 2014:9706072014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chan MC, Hilyard AC, Wu C, et al:
Molecular basis for antagonism between PDGF and the TGFbeta family
of signalling pathways by control of miR-24 expression. EMBO J.
29:559–573. 2010. View Article : Google Scholar :
|
12
|
Elia L, Quintavalle M, Zhang J, et al: The
knockout of miR-143 and -145 alters smooth muscle cell maintenance
and vascular homeostasis in mice: correlates with human disease.
Cell Death Differ. 16:1590–1598. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang C: MicroRNA-145 in vascular smooth
muscle cell biology: a new therapeutic target for vascular disease.
Cell Cycle. 8:3469–3473. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu X, Cheng Y, Zhang S, et al: A
necessary role of miR-221 and miR-222 in vascular smooth muscle
cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Louis WJ and Howes LG: Genealogy of the
spontaneously hypertensive rat and Wistar-Kyoto rat strains:
Implications for studies of inherited hypertension. J Cardiovasc
Pharmacol. 16(Suppl 7): S1–S5. 1990. View Article : Google Scholar : PubMed/NCBI
|
16
|
Uehara Y, Numabe A, Kawabata Y, et al:
Rapid smooth muscle cell growth and endogenous prostaglandin system
in spontaneously hypertensive rats. Am J Hypertens. 4:806–814.
1991. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yu ML, Wang JF, Wang GK, et al: Vascular
smooth muscle cell proliferation is influenced by let-7d microRNA
and its interaction with KRAS. Circ J. 75:703–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lu S, Sun X, Hong T, et al: Isolation and
culture of smooth muscle cells from human acute type A aortic
dissection. J Cardiothorac Surg. 8:832013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao Y, Ransom JF, Li A, et al:
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle
in mice lacking miRNA-1–2. Cell. 129:303–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
van Rooij E, Sutherland LB, Qi X, et al:
Control of stress-dependent cardiac growth and gene expression by a
microRNA. Science. 316:575–579. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Walenkamp MJ, Losekoot M and Wit JM:
Molecular IGF-1 and IGF-1 receptor defects: from genetics to
clinical management. Endocr Dev. 24:128–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chen JF, Mandel EM, Thomson JM, et al: The
role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation. Nat Genet. 38:228–233. 2006.
View Article : Google Scholar
|
23
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nasser MW, Datta J, Nuovo G, et al:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Rodriguez-Nieto S and Sanchez-Cespedes M:
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome
19p and lung cancer. Carcinogenesis. 30:547–554. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Hou X, Tang Z, Liu H, et al: Discovery of
microRNAs associated with myogenesis by deep sequencing of serial
developmental skeletal muscles in pigs. PLoS One. 7:e521232012.
View Article : Google Scholar
|
27
|
Luong HT, Chaplin J, McRae AF, Medland SE,
Willemsen G, Nyholt DR, Henders AK, Hoekstra C, Duffy DL, et al:
Variation in BMPR1B, TGFRB1 and BMPR2 and control of dizygotic
twinning. Twin Res Hum Genet. 14:408–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Allard D, Figg N, Bennett MR and
Littlewood TD: Akt regulates the survival of vascular smooth muscle
cells via inhibition of FoxO3a and GSK3. J Biol Chem.
283:19739–19747. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Patel VA, Zhang QJ, Siddle K, et al:
Defect in insulin-like growth factor-1 survival mechanism in
atherosclerotic plaque-derived vascular smooth muscle cells is
mediated by reduced surface binding and signaling. Circ Res.
88:895–902. 2011. View Article : Google Scholar
|
30
|
Bennett MR, Evan GI and Schwartz SM:
Apoptosis of human vascular smooth muscle cells derived from normal
vessels and coronary atherosclerotic plaques. J Clin Investig.
95:2266–2274. 1995. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kavurma MM, Figg N, Bennett MR, et al:
Oxidative stress regulates IGF1R expression in vascular
smooth-muscle cells via p53 and HDAC recruitment. Biochem J.
407:79–87. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Pedruzzi E, Guichard C, Ollivier V, et al:
NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced
endoplasmic reticulum stress and apoptosis in human aortic smooth
muscle cells. Mol Cell Biol. 24:10703–10717. 2004. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sandberg EM and Sayeski PP: Jak2 tyrosine
kinase mediates oxidative stress-induced apoptosis in vascular
smooth muscle cells. J Biol Chem. 279:34547–34552. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Song HJ, Lee TS, Jeong JH, Min YS, Shin CY
and Sohn UD: Hydrogen peroxide-induced extracellular
signal-regulated kinase activation in cultured feline ileal smooth
muscle cells. J Pharmacol Exp Ther. 312:391–398. 2005. View Article : Google Scholar
|
35
|
Okura Y, Brink M, Zahid AA, Anwar A and
Delafontaine P: Decreased expression of insulin-like growth
factor-1 and apoptosis of vascular smooth muscle cells in human
atherosclerotic plaque. J Mol Cell Cardiol. 33:1777–1789. 2001.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Bennett MR, Littlewood TD, Schwartz SM and
Weissberg PL: Increased sensitivity of human vascular smooth muscle
cells from atherosclerotic plaques to p53-mediated apoptosis. Circ
Res. 81:591–599. 1997. View Article : Google Scholar : PubMed/NCBI
|
37
|
Chan SW, Hegyi L, Scott S, et al:
Sensitivity to Fas-mediated apoptosis is determined below receptor
level in human vascular smooth muscle cells. Circ Res.
86:1038–1046. 2000. View Article : Google Scholar : PubMed/NCBI
|
38
|
Liang Y, Jing Z, Deng H, Li Z, Zhuang Z,
Wang S and Wang Y: Soluble epoxide hydrolase inhibition ameliorates
proteinuria-induced epithelial-mesenchymal transition by regulating
the PI3K-Akt-GSK-3β signaling pathway. Biochem Biophys Res Commun.
463:70–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Liu Y, Zhang J, Yi B, Chen M, Qi J, Yin Y,
Lu X, Jasmin JF and Sun J: Nur77 suppresses pulmonary artery smooth
muscle cell proliferation through inhibition of the
STAT3/Pim-1/NFAT pathway. Am J Respir Cell Mol Biol. 50:379–388.
2014.
|
40
|
Hamfjord J, Stangeland AM, Hughes T, et
al: Differential expression of miRNAs in colorectal cancer:
comparison of paired tumor tissue and adjacentnormal mucosa using
high-throughput sequencing. PLoS One. 7:e341502012. View Article : Google Scholar
|
41
|
Mitra S, Goyal T and Mehta JL: Oxidized
LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 25:419–429.
2011. View Article : Google Scholar : PubMed/NCBI
|
42
|
Stoneman VE and Bennett MR: Role of
apoptosis in atherosclerosis and its therapeutic implications. Clin
Sci (Lond). 107:343–354. 2004. View Article : Google Scholar
|
43
|
Conover CA, Bale LK, Harrington SC, et al:
Cytokine stimulation of pregnancy-associated plasma protein A
expression in human coronary artery smooth muscle cells: inhibition
by resveratrol. Am J Physiol Cell Physiol. 290:C183–C188. 2006.
View Article : Google Scholar
|